FINAL FOR DISTRIBUTION PSIOXUS THERAPEUTICS RAISES A £25M SERIES C INVESTMENT TO PROGRESS ONCOLYTIC VIRUS PLUS CHECKPOINT INHIBITOR COMBINATION STUDY IN METASTATIC COLORECTAL CANCER OXFORD, UK – 19 May 2015 – PsiOxu - Cancer Research UK - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2015-05-19 03:49:40 Experimental cancer treatments Oncolytic virus Immunology Medical research Immunotherapy Gene therapy Reolysin Medicine Biology Viruses		FINAL FOR DISTRIBUTION PSIOXUS THERAPEUTICS RAISES A £25M SERIES C INVESTMENT TO PROGRESS ONCOLYTIC VIRUS PLUS CHECKPOINT INHIBITOR COMBINATION STUDY IN METASTATIC COLORECTAL CANCER OXFORD, UK – 19 May 2015 – PsiOxu Add to Reading List Source URL: www.psioxus.com Download Document from Source Website File Size: 246,17 KB Share Document on Facebook

	Bioluminescent orthotopic PDX models of primary pancreatic cancer and residual/metastatic breast cancer to predict efficacy of standard of care and experimental treatments Benjamin G. 1 Cuiffo , DocID: 1uQqF - View Document
	Intralesional therapy is a possible treatment option for patients with metastatic melanoma due to its good local response and tolerable adverse-event profile. Photo courtesy of Dina Potter. Sunny Tree. 48" × 60". DocID: 1rePY - View Document
	FOR IMMEDIATE RELEASE DocID: 1pOi3 - View Document
	WORLD PRECLINICAL CONGRESS June 14-17, 2016 Westin Boston Waterfront, Boston, MA DocID: 1nhVB - View Document
	Late Breaking Abstracts Addendum Late Breaking Abstracts: Presented at the American Society of Gene & Cell Therapy’s 16th Annual Meeting, May 15-18, 2013, Salt Lake City, Utah DocID: 1gtbO - View Document